Table 3 Application: results under the partial pooling random-effects model with different priors
Parameter (Subgroup, N Studies) | Diffuse Priors | Constrained Priors Set 1 | Constrained Priors Set 2 |
|---|---|---|---|
Analysis: Cardiovascular Studies Left-Out (3 Subgroups in Model Fitting) | |||
Mean \(\beta\) | -0.30(-0.85,0.2) | -0.30(-0.68,0.02) | -0.30(-0.61,-0.06) |
Between-Subgroup SD of \(\beta\) | 0.15(0.01,1.53) | 0.13(0.01,0.77) | 0.12(0.01,0.55) |
\(\beta _1\) (CKD, 28) | -0.25(-0.39,-0.13) | -0.25(-0.38,-0.13) | -0.25(-0.37,-0.13) |
\(\beta _2\) (Diabetes, 21) | -0.30(-0.48,-0.13) | -0.30(-0.48,-0.14) | -0.30(-0.48,-0.15) |
\(\beta _3\) (Glomerular Diseases, 10) | -0.35(-0.66,-0.16) | -0.35(-0.66,-0.17) | -0.35(-0.66,-0.18) |
Analysis: Small Intervention Subgroups Left-Out (7 Subgroups in Model Fitting) | |||
Mean \(\beta\) | -0.41(-0.75,-0.13) | -0.41(-0.74,-0.13) | -0.4(-0.68,-0.18) |
Between-Subgroup SD of \(\beta\) | 0.19(0.02,0.73) | 0.18(0.02,0.70) | 0.15(0.01,0.47) |
\(\beta _1\) (Antiplatelets, 3) | -0.39(-1.03,0.34) | -0.39(-1.01,0.33) | -0.39(-0.88,0.14) |
\(\beta _2\) (DPP-4, 3) | -0.40(-1.04,0.16) | -0.40(-1.01,0.14) | -0.39(-0.89,0.04) |
\(\beta _3\) (Immunosuppressants, 9) | -0.47(-0.92,-0.23) | -0.47(-0.94,-0.24) | -0.46(-0.87,-0.24) |
\(\beta _4\) (Modify Blood Pressure, 7) | -0.45(-0.84,-0.18) | -0.44(-0.83,-0.17) | -0.43(-0.78,-0.18) |
\(\beta _5\) (RASB vs CCB, 4) | -0.41(-0.81,-0.06) | -0.41(-0.79,-0.06) | -0.41(-0.75,-0.14) |
\(\beta _6\) (RASB vs Control, 21) | -0.50(-0.82,-0.25) | -0.49(-0.82,-0.24) | -0.47(-0.75,-0.23) |
\(\beta _7\) (SGLT-2, 4) | -0.25(-0.49,0.01) | -0.25(-0.49,0.00) | -0.27(-0.48,-0.07) |